142 related articles for article (PubMed ID: 36171757)
1. Dengue activates mTORC2 signaling to counteract apoptosis and maximize viral replication.
Carter CC; Mast FD; Olivier JP; Bourgeois NM; Kaushansky A; Aitchison JD
Front Cell Infect Microbiol; 2022; 12():979996. PubMed ID: 36171757
[TBL] [Abstract][Full Text] [Related]
2. Head and neck cancer stem cell maintenance relies on mTOR signaling, specifically involving the mechanistic target of rapamycin complexes 1 and 2 (mTORC1 and mTORC2).
Almeida LO; Silva LC; Emerick C; Amorim Dos Santos J; Castilho RM; Squarize CH
Arch Oral Biol; 2024 Jan; 157():105840. PubMed ID: 37939517
[TBL] [Abstract][Full Text] [Related]
3. NOP14-mediated ribosome biogenesis is required for mTORC2 activation and predicts rapamycin sensitivity.
Yan X; Kuang BH; Ma S; Wang R; Lin J; Zeng YX; Xie X; Feng L
J Biol Chem; 2024 Mar; 300(3):105681. PubMed ID: 38272224
[TBL] [Abstract][Full Text] [Related]
4. Phosphoproteomic Analysis Defines BABAM1 as mTORC2 Downstream Effector Promoting DNA Damage Response in Glioblastoma Cells.
Kalpongnukul N; Bootsri R; Wongkongkathep P; Kaewsapsak P; Ariyachet C; Pisitkun T; Chantaravisoot N
J Proteome Res; 2022 Dec; 21(12):2893-2904. PubMed ID: 36315652
[TBL] [Abstract][Full Text] [Related]
5. mTOR Regulation of N-Myc Downstream Regulated 1 (NDRG1) Phosphorylation in Clear Cell Renal Cell Carcinoma.
Valluri A; Wellman J; McCallister CL; Brown KC; Lawrence L; Russell R; Jensen J; Denvir J; Valentovic MA; Denning KL; Salisbury TB
Int J Mol Sci; 2023 May; 24(11):. PubMed ID: 37298315
[TBL] [Abstract][Full Text] [Related]
6. Regulation of mTORC2 Signaling.
Fu W; Hall MN
Genes (Basel); 2020 Sep; 11(9):. PubMed ID: 32899613
[TBL] [Abstract][Full Text] [Related]
7. Cystine Induced-mTORC2 Activation through Promoting Sin1 Phosphorylation to Suppress Cancer Cell Ferroptosis.
Wang G; Chen L; Qin S; Zheng Y; Xia C; Yao J; Wang P; Deng L
Mol Nutr Food Res; 2022 Dec; 66(23):e2200186. PubMed ID: 36189894
[TBL] [Abstract][Full Text] [Related]
8. Expression of mTOR in normal and pathological conditions.
Marques-Ramos A; Cervantes R
Mol Cancer; 2023 Jul; 22(1):112. PubMed ID: 37454139
[TBL] [Abstract][Full Text] [Related]
9. mTORC2: a multifaceted regulator of autophagy.
Sun Y; Wang H; Qu T; Luo J; An P; Ren F; Luo Y; Li Y
Cell Commun Signal; 2023 Jan; 21(1):4. PubMed ID: 36604720
[TBL] [Abstract][Full Text] [Related]
10. A bi-steric mTORC1-selective inhibitor overcomes drug resistance in breast cancer.
Meng D; Zhao X; Yang YC; Navickas A; Helland C; Goodarzi H; Singh M; Bandyopadhyay S
Oncogene; 2023 Jul; 42(28):2207-2217. PubMed ID: 37264081
[TBL] [Abstract][Full Text] [Related]
11. mTORC1 and mTORC2 in cancer and the tumor microenvironment.
Kim LC; Cook RS; Chen J
Oncogene; 2017 Apr; 36(16):2191-2201. PubMed ID: 27748764
[TBL] [Abstract][Full Text] [Related]
12. Using
Frappaolo A; Giansanti MG
Cells; 2023 Nov; 12(22):. PubMed ID: 37998357
[TBL] [Abstract][Full Text] [Related]
13. UCH-L1 bypasses mTOR to promote protein biosynthesis and is required for MYC-driven lymphomagenesis in mice.
Hussain S; Bedekovics T; Liu Q; Hu W; Jeon H; Johnson SH; Vasmatzis G; May DG; Roux KJ; Galardy PJ
Blood; 2018 Dec; 132(24):2564-2574. PubMed ID: 30257881
[TBL] [Abstract][Full Text] [Related]
14. The mTORC2 signaling network: targets and cross-talks.
Ragupathi A; Kim C; Jacinto E
Biochem J; 2024 Jan; 481(2):45-91. PubMed ID: 38270460
[TBL] [Abstract][Full Text] [Related]
15. The mTORC1 pathway participate in hyper-function of B cells in immune thrombocytopenia.
Xiang Y; Liu L; Hou Y; Du S; Xu S; Zhou H; Shao L; Li G; Yu T; Liu Q; Xue M; Yang J; Peng J; Hou M; Shi Y
Ann Hematol; 2023 Sep; 102(9):2317-2327. PubMed ID: 37421506
[TBL] [Abstract][Full Text] [Related]
16. Genetic inactivation of mTORC1 or mTORC2 in neurons reveals distinct functions in glutamatergic synaptic transmission.
McCabe MP; Cullen ER; Barrows CM; Shore AN; Tooke KI; Laprade KA; Stafford JM; Weston MC
Elife; 2020 Mar; 9():. PubMed ID: 32125271
[TBL] [Abstract][Full Text] [Related]
17. mTORC2 Is Activated under Hypoxia and Could Support Chronic Myeloid Leukemia Stem Cells.
Panuzzo C; Pironi L; Maglione A; Rocco S; Stanga S; Riganti C; Kopecka J; Ali MS; Pergolizzi B; Bracco E; Cilloni D
Int J Mol Sci; 2023 Jan; 24(2):. PubMed ID: 36674750
[TBL] [Abstract][Full Text] [Related]
18. mTOR signaling in renal ion transport.
Adella A; de Baaij JHF
Acta Physiol (Oxf); 2023 May; 238(1):e13960. PubMed ID: 36906912
[TBL] [Abstract][Full Text] [Related]
19. TBK1-mTOR Signaling Attenuates Obesity-Linked Hyperglycemia and Insulin Resistance.
Bodur C; Kazyken D; Huang K; Tooley AS; Cho KW; Barnes TM; Lumeng CN; Myers MG; Fingar DC
Diabetes; 2022 Nov; 71(11):2297-2312. PubMed ID: 35983955
[TBL] [Abstract][Full Text] [Related]
20. Growth or death? Control of cell destiny by mTOR and autophagy pathways.
Khalil MI; Ali MM; Holail J; Houssein M
Prog Biophys Mol Biol; 2023 Dec; 185():39-55. PubMed ID: 37944568
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
